The official page of the University of Colorado Anschutz Cancer Center - Colorado's only National Cancer Institute-designated cancer center.
Located on the Anschutz Medical Campus, the University of Colorado Cancer Center is Colorado’s only National Cancer Institute-designated comprehensive cancer center, a distinction recognizing its outstanding contributions to research, clinical trials, prevention and cancer control. CU Cancer Center is a member of the prestigious National Comprehensive Cancer Network®, an alliance of the nation’s l
eading cancer centers working to establish and deliver the gold standard in cancer clinical guidelines. NCI website: http://www.cancer.gov
National Comprehensive Cancer Network Website: http://www.nccn.org
04/23/2026
“We want to target the way they're trying to adapt and survive and make that resistance into a vulnerability,” says Kyle Concannon, MD, a CU Anschutz Cancer Center member.
Learn more about this lung cancer research that Concannon presented at the annual meeting of the American Association for Cancer Research (AACR) ⬇️
Kyle Concannon, MD, presented his latest research on lung cancer resistor cells at the annual meeting of the American Association for Cancer Research.
04/22/2026
Have you heard of some of these myths about head and neck cancers?
"Only to***co users get head and neck cancer." "Mouthwash prevents oral cancer." "Mobile phones can cause head and neck cancer."
For Head and Neck Cancer Awareness Month, Carissa Thomas, MD, PhD, FACS, busts these common myths and more ⬇️
Cancer is a topic that can inspire uncertainty, fear, and misconceptions. And when it comes to head and neck cancers, myths abound. Here are the facts.
04/21/2026
“All patients, but particularly early-onset adults, should have a full team providing multidisciplinary, holistic care,” said CU Anschutz Cancer Center leader Christopher Lieu, MD, while he was a panel moderator at the National Comprehensive Cancer Network 2026 Annual Conference.
Read more about the conference ⬇️
Pressing issues in oncology, including rising cancer incidences in younger people, plus global opportunities for improving outcomes, were presented alongside cutting-edge research and clinical guidelines updates, during yearly event hosted by the National Comprehensive Cancer Network.
04/21/2026
At the 50th Annual Meeting of the American Society of Preventive Oncology, CU Anschutz Cancer Center Postdoctoral Fellow Erin Hirsch, PhD, MSPH, MSCS, presented on research about how those at higher risk of lung cancer view screening messages.
Learn what this research may mean for lung cancer screening ⬇️
CU Anschutz Cancer Center postdoc fellow shows how empathetic, empowering messaging can reduce lung cancer screening stigma, build trust, and save lives.
04/20/2026
Focused on advancing care for children with cancer, Lia Gore, MD, is a nationally recognized pediatric oncologist, physician-scientist, and a CU Anschutz Cancer Center leader. She serves as the section head of pediatric hematology/oncology and bone marrow transplant and drives research in clinical trials, leukemia, and new therapies.
Sachin Wani, MD, a CU Anschutz Cancer Center member, explains that “silent reflux” — which can be less noticeable — still poses risks for complications, such as Barrett’s esophagus and esophageal cancer.
Learn more about silent-reflux ⬇️
CU Anschutz gastroenterologist Sachin Wani, MD, explains that some people experiencing laryngopharyngeal reflux may not have classic heartburn symptoms.
04/16/2026
CU Anschutz Cancer Center researchers find that breast cancer cells that spread to the lungs may take advantage of the body’s natural healing response. The team is evaluating roflumilast, a medication approved to treat Chronic Obstructive Pulmonary Disease (COPD), as a way to slow tumor cell growth in the lungs.
Learn more about this research ⬇️
Breast Cancer Hijacks the Lung Repair System to Fuel Tumor Growth, Study Finds
04/16/2026
What is an MCD test, and how might it change the future of cancer detection? 👩⚕️👨⚕️
Linda Cook, PhD, and Jamie Studts, PhD, from the CU Anschutz Cancer Center explain what multi-cancer early detection testing is, why it’s important, and how it could help patients.
Filmed at 2026
04/15/2026
The University of Colorado Anschutz Cancer Center was delighted to welcome the 50th Annual Conference of the American Society of Preventive Oncology (ASPO) to Colorado over the past few days.
Members presented at symposia, oral sessions, and poster sessions, highlighting the center’s strengths in cancer prevention, screening, survivorship, and health equity. Topics included multi-cancer detection tests, geographic context in cancer care, lung cancer screening communication, survivorship care pathways, nutrition interventions, and research on sarcopenia and fall risk in older breast cancer patients.
These contributions demonstrate the breadth and impact of our faculty’s work and ASPO’s commitment to improving cancer outcomes. Thank you to everyone who contributed to this successful milestone meeting.
04/10/2026
If she could speak to her former self, Tin Tin Su, PhD, would say: don’t be afraid of what you will find. Let go of expectations about how results should look and trust the process of discovery.
Barrett’s esophagus (BE) is the only known condition that precedes esophageal adenocarcinoma. Researchers have developed a new artificial intelligence (AI)–based tool that shows promise for improving surveillance in patients treated with endoscopic eradication therapies for BE-related dysplasia.
For Esophageal Cancer Awareness Month, learn about this new tool ⬇️
Researchers Develop AI Tool to Predict Barrett’s Esophagus Recurrence After Therapy
04/09/2026
This year’s American Society of Preventive Oncology Annual Conference marks 50 Years of Impact: honoring the work that has advanced cancer prevention research for decades.
Don’t miss sessions from ASPO’s key presenters highlighting innovation, collaboration, and community-driven prevention.
Be the first to know and let us send you an email when University of Colorado Anschutz Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Located on the Anschutz Medical Campus, the University of Colorado Cancer Center is Colorado’s only National Cancer Institute-designated comprehensive cancer center, a distinction recognizing its outstanding contributions to research, clinical trials, prevention and cancer control. CU Cancer Center is a member of the prestigious National Comprehensive Cancer Network®, an alliance of the nation’s leading cancer centers working to establish and deliver the gold standard in cancer clinical guidelines. CU Cancer Center is a consortium of more than 400 researchers and physicians at three state universities and six institutions, all working toward one goal: Translating science into life.
Mission
To discover, develop and deliver breakthroughs in diagnosis, treatment, and prevention that improve cancer care locally, nationally and globally. These efforts form the basis of a comprehensive spectrum of translational prevention, diagnosis, treatment, survivorship and outreach programs and provide a framework for training the next generation of cancer researchers and physicians.
Vision
To transform cancer research and practice in the state of Colorado by creating an integrated interdisciplinary nexus of clinicians and scientists across our statewide consortium that can leverage, synergize, marshal and focus resources and expertise to discover new ways to prevent and treat cancer.
NCI website: http://www.cancer.gov
National Comprehensive Cancer Network Website: http://www.nccn.org
